WELOXY LIMITED

1. Financial Health Score: C+

Explanation: WELOXY LIMITED is in a stable but sluggish condition. Like a patient with a chronic cough who is otherwise able to walk around, the business is solvent and can meet its immediate obligations, but it is showing symptoms of declining vitality. The persistent, high level of debt relative to its size and the recent drop in overall net worth suggest that while the company is not in intensive care, it is far from peak physical fitness.

2. Key Vital Signs

• Net Assets (Financial Blood Pressure): £55,856 (down from £64,606 in 2024). Interpretation: The company’s net worth is positive, meaning it has more assets than liabilities. However, the drop of nearly £8,750 in the last year is like a drop in blood pressure—it indicates the business is bleeding value, either through operational losses or significant dividend extractions.
• Current Assets vs. Current Liabilities (Immune System): £143,586 vs. £87,730. Interpretation: This yields a current ratio of approximately 1.6. The company has enough short-term assets to comfortably cover its short-term debts. Its immediate immune response is healthy, meaning it can fend off sudden cash demands.
• Total Liabilities (Cholesterol Levels): £87,730 (virtually unchanged from £87,757 in 2024). Interpretation: This is a chronic build-up. For a micro-entity with zero employees, this level of persistent debt acts like high cholesterol, restricting the financial flexibility of the business. The fact that it has barely shifted year-on-year suggests this debt is being serviced but not cleared.
• Cash Reserves (Respiratory Rate): Historically erratic (ranging from £18 to £16,543 in recent years). Interpretation: While specific cash figures for 2025 are not disclosed, the historical volatility suggests the company’s breathing can become very shallow. An IT consultancy relies on steady cash flow to survive; when cash drops to near-zero, the business is holding its breath.

3. Symptoms Analysis & Diagnosis

Symptoms Analysis: The most glaring symptom in WELOXY LIMITED is the stark contrast between its asset growth and its liability stagnation. Between 2023 and 2024, the company experienced a massive injection of assets (growing from £41,832 to £150,698), but its liabilities also ballooned (from £7,193 to £87,757). In the latest 2025 year, assets have slightly contracted, while liabilities remain glued to the £87k mark.

Because the director has elected not to file a Profit & Loss account (as is their legal right for a micro-entity), we cannot see the exact "caloric intake" (revenue) or "burn rate" (expenses). However, the drop in net assets strongly implies that the business is either operating at a loss or the director is extracting value faster than the business is generating it.

Diagnosis: Chronic Debt-Induced Fatigue with Mild Equity Attrition The patient is suffering from a persistent debt load that is dragging on its overall health. While the business is not insolvent (its "heart" is still beating with positive net assets), the stagnant liabilities and declining equity show a business that is working hard just to maintain the status quo, rather than building financial muscle. The absence of any employees confirms this is a solo practice, meaning the entire burden of this financial health rests on the shoulders of one individual.

4. Prognosis & Recommendations

Prognosis: The future outlook is stable but guarded. As long as current assets can be converted into cash (i.e., client invoices are paid on time), the company will continue to survive. However, the erratic cash history and high liabilities make it vulnerable to shocks, such as a downturn in the IT consultancy market or the loss of a major client. Without addressing the debt, the business will remain in a state of financial fatigue.

Recommendations: 1. Debt Reduction Prescribed: The company must implement a structured plan to pay down the £87,730 in current liabilities. Even reducing this by 20-30% would significantly improve the company’s financial flexibility and lower its "cholesterol." 2. Cash Flow Diet: Given the historical volatility of cash reserves, the business needs to build a minimum cash buffer (e.g., 3 months of operating expenses) to ensure it doesn't suffer from financial asphyxiation during lean months. 3. Monitor the Weight Loss: The decline in net assets needs to be investigated. If the drop is due to trading losses, the business model needs a review to ensure rates are sufficient. If it is due to director dividends, the director should ensure they are not bleeding the company dry of its necessary working capital. 4. Improve Financial Transparency: While filing as a micro-entity keeps administrative burdens low, the lack of a P&L makes it difficult to diagnose the root cause of the equity drop. Even basic internal management accounts should be maintained to track profitability month-by-month.